Achieving FDA and EMA Compliance in Temperature Monitoring

Freezer for temperature monitoring.
Document
Achieving FDA and EMA Compliance in Temperature Monitoring

Pharmaceuticals and biologics often require strict temperature monitoring to stay safe and effective. Deviation from these conditions can cause degradation. Regulatory bodies like the FDA and EMA enforce strict guidelines to ensure product quality during manufacturing, storage, and transport.

Many pharmaceuticals and biological products require specific temperature conditions during manufacturing, storage, and transport to ensure their quality and safety. Failure to maintain these conditions can lead to product degradation, making them less effective or even dangerous.
Key Considerations for Life Science Companies

To protect public health, regulatory authorities like the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have established strict guidelines to manage these products. To comply with these regulations, life science companies must adopt advanced temperature monitoring systems that can track and record conditions continuously and reliably.

This whitepaper explains the main requirements from both the FDA and EMA, the role of technology in maintaining compliance, and the best practices for setting up effective temperature monitoring systems.

You may also be interested in

TSS Sponsors the 27th Annual Clinical Trial Supply Europe 2026 in Barcelona

TSS is proud to sponsor the 27th Annual Clinical Trial Supply Europe, taking place 24–25 February 2026 in Barcelona, Spain. The event brings together clinical supply professionals, sponsors, CROs, and solution providers to discuss how to strengthen resilience, quality, and patient safety across the clinical trial supply chain.
Read moreDownload Whitepaper

New opportunities on the horizon as TSS expands US operations

We are expanding our US operations, with Evan Hahn to be the new VP North America. Evan brings a wealth of knowledge of the pharmaceutical clinical trial space, supporting the TSS launch of its new offering in this category.
Read moreDownload Whitepaper
A digitally tracked package on a conveyor system, representing a digital transformation of the supply chain.

Is your supply chain ready for a digital transformation?

Without a doubt, uncertainty and unpredictability will continue to increase. Whether you‘re a pharmaceutical company dealing with temperature excursions, or a manufacturer relying on critical assembly-line components, you’re bound to be affected. The amount of disruption in today’s business climate demands the ability to respond quickly, which can only be done if the entire supply chain is visible.
Read moreDownload Whitepaper

You may also be interested in

Meet Us at GCSG 2026 in Rome

TSS will be joining the GCSG 2026 European Knowledge Forum, taking place October 13–15 in Rome, Italy.
Read more

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.